-
公开(公告)号：US11154495B2
公开(公告)日：2021-10-26
申请号：US15092332
申请日：2016-04-06
发明人： Ovidiu Romanoschi , Caryn Oryniak , Luis Muniz , Lindsey Bagley , Graham Godfrey , Hiep Huatan
IPC分类号： A61K9/00 , A61K45/06 , A61K33/42 , A23G3/36 , A23G3/54 , A61K9/20 , A61K31/167 , A61K31/19 , A61K31/197 , A61K31/375 , A61K31/4545 , A61K31/519 , A61K31/616
摘要： The present disclosure provides oral, chewable dosage forms that are suitable for delivery of one or more active ingredients to a consumer, particularly a human individual. The dosage forms can be configured as multicomponent compositions formed of a first component including a gummy composition, at least one further component including a composition that is different from the gummy composition, and an active ingredient. The gummy composition and the second composition can be co-deposited to form multicomponent dosage forms wherein a gummy shell at least partially surrounds a core that is solid or liquid at standard temperature.
-
公开(公告)号：US20160296470A1
公开(公告)日：2016-10-13
申请号：US15092332
申请日：2016-04-06
发明人： Ovidiu Romanoschi , Caryn Oryniak , Luis Muniz , Lindsey Bagley , Graham Godfrey , Hiep Huatan
CPC分类号： A61K9/0056 , A23G3/36 , A23G3/54 , A23V2002/00 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2072 , A61K31/167 , A61K31/19 , A61K31/197 , A61K31/375 , A61K31/4545 , A61K31/519 , A61K31/616 , A61K33/42 , A61K45/06 , A61K2300/00
摘要： The present disclosure provides oral, chewable dosage forms that are suitable for delivery of one or more active ingredients to a consumer, particularly a human individual. The dosage forms can be configured as multicomponent compositions formed of a first component including a gummy composition, at least one further component including a composition that is different from the gummy composition, and an active ingredient. The gummy composition and the second composition can be co-deposited to form multicomponent dosage forms wherein a gummy shell at least partially surrounds a core that is solid or liquid at standard temperature.
摘要翻译： 本公开提供适于将一种或多种活性成分递送给消费者，特别是人类个体的口服咀嚼剂型。 剂型可以被配置为由包含胶质组合物的第一组分形成的多组分组合物，至少一种其它组分，包括不同于胶质组合物的组合物和活性成分。 胶粘组合物和第二组合物可以共沉积以形成多组分剂型，其中胶状壳至少部分地围绕在标准温度下为固体或液体的核心。
-
公开(公告)号：US10786447B2
公开(公告)日：2020-09-29
申请号：US16437808
申请日：2019-06-11
发明人： Ovidiu Romanoschi , Caryn Oryniak , Luis C. Muniz , Hiep Huatan , Nazim Kanji , Huw Jones , Lindsey Bagley , Graham Godfrey
IPC分类号： A61K9/00 , A61K45/06 , A61K33/42 , A23G3/36 , A23G3/54 , A61K9/20 , A61K31/167 , A61K31/19 , A61K31/197 , A61K31/375 , A61K31/4545 , A61K31/519 , A61K31/616
摘要： The present disclosure provides oral, chewable dosage forms that are suitable for delivery of one or more active ingredients to a consumer, particularly a human individual. The dosage forms can be configured as multicomponent compositions formed of: a first component including a gummy composition; a second component that is a particulate material or is a pre-formed solid unit or plurality of pre-formed solid units; and an active ingredient. The second component can be, for example, in the form of a pharmaceutically acceptable oral dosage unit, such as a tablet, a caplet, a soft shell capsule, a hard shell capsule, a microcapsule, or a pastille.
-
公开(公告)号：US20200000716A1
公开(公告)日：2020-01-02
申请号：US16437808
申请日：2019-06-11
发明人： Ovidiu Romanoschi , Caryn Oryniak , Luis C. Muniz , Hiep Huatan , Nazim Kanji , Huw Jones , Lindsey Bagley , Graham Godfrey
IPC分类号： A61K9/00 , A61K45/06 , A61K33/42 , A23G3/36 , A23G3/54 , A61K9/20 , A61K31/167 , A61K31/19 , A61K31/197 , A61K31/375 , A61K31/4545 , A61K31/519 , A61K31/616
摘要： The present disclosure provides oral, chewable dosage forms that are suitable for delivery of one or more active ingredients to a consumer, particularly a human individual. The dosage forms can be configured as multicomponent compositions formed of: a first component including a gummy composition; a second component that is a particulate material or is a pre-formed solid unit or plurality of pre-formed solid units; and an active ingredient. The second component can be, for example, in the form of a pharmaceutically acceptable oral dosage unit, such as a tablet, a caplet, a soft shell capsule, a hard shell capsule, a microcapsule, or a pastille.
-
公开(公告)号：US10328023B2
公开(公告)日：2019-06-25
申请号：US15092283
申请日：2016-04-06
发明人： Ovidiu Romanoschi , Caryn Oryniak , Luis C. Muniz , Hiep Huatan , Nazim Kanji , Huw Jones , Lindsey Bagley , Graham Godfrey
IPC分类号： A61K9/00 , A61K45/06 , A23G3/54 , A23G3/36 , A61K9/24 , A61K9/20 , A61K31/375 , A61K31/19 , A61K31/519 , A61K31/167 , A61K31/197 , A61K31/616 , A61K31/4545 , A61K33/42
摘要： The present disclosure provides oral, chewable dosage forms that are suitable for delivery of one or more active ingredients to a consumer, particularly a human individual. The dosage forms can be configured as multicomponent compositions formed of: a first component including a gummy composition; a second component that is a particulate material or is a pre-formed solid unit or plurality of pre-formed solid units; and an active ingredient. The second component can be, for example, in the form of a pharmaceutically acceptable oral dosage unit, such as a tablet, a caplet, a soft shell capsule, a hard shell capsule, a microcapsule, or a pastille.
-
公开(公告)号：US20160296474A1
公开(公告)日：2016-10-13
申请号：US15092283
申请日：2016-04-06
发明人： Ovidiu Romanoschi , Caryn Oryniak , Luis C. Muniz , Hiep Huatan , Nazim Kanji , Huw Jones , Lindsey Bagley , Graham Godfrey
IPC分类号： A61K9/20 , A61K9/00 , A61K31/616 , A61K31/4545 , A23G3/36 , A61K31/375 , A61K31/197 , A61K31/519 , A61K45/06 , A23G3/54 , A61K31/167 , A61K31/19
CPC分类号： A61K9/0056 , A23G3/36 , A23G3/54 , A23V2002/00 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2072 , A61K31/167 , A61K31/19 , A61K31/197 , A61K31/375 , A61K31/4545 , A61K31/519 , A61K31/616 , A61K33/42 , A61K45/06 , A61K2300/00
摘要： The present disclosure provides oral, chewable dosage forms that are suitable for delivery of one or more active ingredients to a consumer, particularly a human individual. The dosage forms can be configured as multicomponent compositions formed of: a first component including a gummy composition; a second component that is a particulate material or is a pre-formed solid unit or plurality of pre-formed solid units; and an active ingredient. The second component can be, for example, in the form of a pharmaceutically acceptable oral dosage unit, such as a tablet, a caplet, a soft shell capsule, a hard shell capsule, a microcapsule, or a pastille.
摘要翻译： 本公开提供适于将一种或多种活性成分递送给消费者，特别是人类个体的口服咀嚼剂型。 剂型可以构成为由以下组成的多组分组合物：包含胶质组合物的第一组分; 作为颗粒材料的第二组分或预成形固体单元或多个预成形固体单元; 和活性成分。 第二组分可以是例如药学上可接受的口服剂量单位形式，例如片剂，囊片，软壳胶囊，硬壳胶囊，微胶囊或糊状物。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.015 秒)
